Amgen's Prolia Gains First Regulatory Win: Market Approval in Europe
This article was originally published in The Pink Sheet Daily
Executive Summary
Amgen and GlaxoSmithKline will assume marketing responsibilities in Europe for osteoporosis, and Amgen will market it for oncology.